Clinical review finds limited evidence on the effectiveness of tumor surveillance in children with cancer predisposition syndromes, highlighting a need for systematic outcome data.
Pediatric oncology patients are increasingly recognized as having an underlying cancer predisposition syndrome (CPS). Surveillance is often recommended to detect new tumors at their earliest and most curable stages. Data on the effectiveness and outcomes of surveillance for children with CPS are limited.
No takes yet. Share an insight, caveat, or question.
Blake et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: